netFormulary NHS
Southampton Joint Formulary
 Introduction

Welcome to the Southampton Joint Medicines Formulary

Useful Links

Shared care guidelines DPC medicines guidance
Immunoglobulin forms

Formulary applications (UHS)

Formulary applications (Southampton CCG)

Southampton City CCG University Hospital Southampton
NHS England Specialised Commissioning Documents  NICE Guidance
Medicines Learning Portal Medicine Safety Portal

 Covid-19 Resources

NICE Covid-19 Rapid guidelines and evidence reviews

 

NHS England and NHS Improvement Coronavirus guidance for clinicians NHS England and NHS Improvement Specialty guides for patient management
Position Statement of the ESC Council on ACE-Inhibitors and ARBs in Covid-19   Renal Association UK position statement on Covid-19 and ACE Inhibitor/Angiotensin Receptor Blocker use
European Medicines Agency advice on the use of non-steroidal anti-inflammatories for Covid-19   UK Government response: Ibuprofen use and Covid19/Coronavirus
ECCO guidance for healthcare professionals on care of patients with IBD including those taking immunosuppressive/ immunomodulatory treatments  COVID-19: BSG and BASL advice for healthcare professionals in Gastroenterology and Hepatology
Asthma UK Covid-19 health advice for people with asthma RCOG Guidance Covid-19 infection and pregnancy 
Endocrine Society advice statement with a summary for adrenal insufficiency patients during the Covid-19 crisis  British Society for Rheumatology Covid-19 update for members
Clinical guide for the management of rheumatology patients during the coronavirus pandemic ABN Guidance on use of disease-modifying therapies in MS in response to threat of Coronavirus eipdemic
International Psoriasis Council Statement On The Coronavirus (Covid-19) Outbreak  British Association of Dermatologists Covid-19 (Coronavirus): interim advice for those taking medicines that affect the immune system
British Association Dermatologists Statement on dry skin and frequent handwashing to reduce Covid-19 risk British Association of Dermatologists statement on shielding of higher risk dermatology patients
British Lung Foundation shielding advice for patients with long-term lung conditions Primary Care Diabetes Society Factsheet for Healthcare professionals: Covid-19 and diabetes
PCWHF Managing contraceptive provision without face-to-face consultations  PSNC Covid-19 Resource Hub for community pharmacists

 

News Feed

March 2020: MHRA Chloroquine and Hydroxychloroquine not licensed for coronavirus (COVID-19) treatment


June 2019: updated NHS England Guidance for CCGs: Items which should not be routinely prescribed in primary care


Drug Shortages or Discontinuations


March 2018: NHS England Guidance for CCGs: Conditions for which over the counter items should not routinely be prescribed in primary care and implementation resources


 

The NHS in and around Southampton and West Hampshire reviews the use of medicines through the Basingstoke, Southampton and Winchester District Prescribing Committee (DPC). The main aim of the DPC is to ensure that there is a consistent approach to prescribing the most safe, efficacious and cost effective medicines across the local healthcare community. The Southampton Joint Medicines Formulary follows recommendations from the DPC, and is for use by all primary and secondary care prescribers within Southampton (See 'about’).

This formulary provides a list of medicines available for routine prescribing or those available within certain criteria. Unless otherwise stated, the medicines selected are recommended as first choice, particularly for new patients. Those patients stabilised on other therapies may be switched to a formulary drug if and when clinically appropriate. 

 


NetFormulary
   Visits = 23484
   Last updated: 30/03/2020 11:48:24..
    Download net formulary from Apple IOS Store  Google Play net formulary